Start an analysis for MATX
Matsons, Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $3.8bnEST | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Remaining authorization | $666mEST | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Program expiry | 31-Dec-29 | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Repurchased last quarter | $59m | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 24-Jun-21 | $3.8bnEST 18.0m sh | $666mEST 3.1m sh left | 31-Dec-29 | On June 24, 2021, Matson’s Board of Directors approved a share repurchase program of up to 3.0 million shares of common stock, with subsequent approvals for the addition of 3.0 million shares on each of January 27, 2022, August 23, 2022, April 27, 2023, February 27, 2025 and April 23, 2026 for an aggregate total of 18.0 million shares of common stock.10-Q filed 05-Nov-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 130,000 | $227.48 | $30m | 10-Q filed 05-Nov-26 |
| 31-Aug-26 | 112,000 | $217.57 | $24m | 10-Q filed 05-Nov-26 |
| 31-Jul-26 | 26,542 | $198.66 | $5m | 10-Q filed 05-Nov-26 |
| 30-Jun-26 | 142,500 | $193.75 | $28m | 10-Q filed 04-Aug-26 |